Article Versions Notes

Bellan M, Piccinino C, Tonello S, Minisini R, Giubertoni A, Sola D, Pedrazzoli R, Gagliardi I, Zecca E, Calzaducca E, et al. Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs). Pharmaceuticals. 2021; 14(5):394. https://doi.org/10.3390/ph14050394

Bellan, Mattia, Cristina Piccinino, Stelvio Tonello, Rosalba Minisini, Ailia Giubertoni, Daniele Sola, Roberta Pedrazzoli, Ileana Gagliardi, Erika Zecca, Elisa Calzaducca, and et al. 2021. "Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)" Pharmaceuticals 14, no. 5: 394. https://doi.org/10.3390/ph14050394

Bellan, M., Piccinino, C., Tonello, S., Minisini, R., Giubertoni, A., Sola, D., Pedrazzoli, R., Gagliardi, I., Zecca, E., Calzaducca, E., Mazzoleni, F., Piffero, R., Patti, G., Pirisi, M., & Sainaghi, P. P. (2021). Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs). Pharmaceuticals, 14(5), 394. https://doi.org/10.3390/ph14050394